Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

@article{Tomblyn2007DifficultSC,
  title={Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma},
  author={Marcie Riches Tomblyn and Linda Jean Burns and B L Blazar and J E Wagner and C Lee and Tyson B. Rogers and PB McGlave and Jeffrey S Miller and Daniel J. Weisdorf},
  journal={Bone Marrow Transplantation},
  year={2007},
  volume={40},
  pages={111-118}
}
Hematopoietic growth factors alone or in combination with myelosuppressive chemotherapy are used to mobilize peripheral blood stem cells for autologous transplantation. To identify characteristics of successful mobilization with granulocyte colony-stimulating factor (G-CSF) alone and to study the impact of immediate chemotherapy mobilization following G-CSF mobilization, we treated 175 chemotherapy sensitive lymphoma patients with G-CSF (G) mobilization and leukapheresis followed by… CONTINUE READING
10 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Cost - effectiveness of repeated aphereses in poor mobilizers undergoing high - dose chemotherapy and autologous hematopoietic

  • R Goterris, JC Hernandez-Boluda, A Teruel, C Gomez, MJ Lis, MJ Terol
  • cell transplantation Leukemia
  • 2003

Similar Papers

Loading similar papers…